Skip to main content
. 2020 Jan 7;73(3):224–231. doi: 10.4097/kja.19396

Table 3.

ROTEM® Parameters

Group A (n=36) Group B (n=23) Survivors (n=61) P value P value
Group A vs. Group B Group A vs. Survivors Group B vs. Survivors
CT (s)
 EXTEM 89 [70–93] 75 [67–84] 70 [60–77] <0.001 0.041 <0.001 0.030
 INTEM 179 [153–193] 174 [153–191] 178 [160–193] 0.750 1.000 1.000 1.000
CFT (s)
 EXTEM 91 [71–106] 83 [54–88] 63 [53–76] <0.001 0.020 <0.001 0.030
 INTEM 75 [55–93] 67 [50–82] 66 [55–76] 0.210 0.650 0.250 1.000
MCF (mm)
 EXTEM 65 [58–74] 66 [56–74 69 [65–75] 0.019 1.000 0.060 0.044
 INTEM 64 [54–71] 67 [56–73] 67 [62–71] 0.640 1.000 1.000 1.000
 FIBTEM 25 [16–41] 26 [16–34] 30 [22–39] 0.130 1.000 0.480 0.160
TDI
 EXTEM 0.42 [0.29–0.50] 0.41 [0.3–0.55] 0.49 [0.43–0.56] 0.001 1.000 0.008 0.005
 INTEM 0.24 [0.18–0.32] 0.27 [0.2–0.34] 0.28 [0.23–0.33] 0.340 0.900 0.450 1.000

Values are presented as median and [IQR]. CT: clotting time, CFT: clot formation time, MCF: maximum clot firmness, TDI: thrombodynamic index. Group A: non-survivors at 28 days, Group B: non-survivors between days 29 and 90 after enrollment.